bioRxiv Science⌕ Search

Biology subjects

Huntley, J.

Publications and source records attributed to Huntley, J..

2 recordsLinked to original sources

Synergistic and redundant information dynamics are modulated by Alzheimer's disease and cognitive impairment

BackgroundThe early diagnosis of Alzheimers disease (AD), a cause of progressive cognitive decline, remains challenging. Recent information-theoretic advances allow brain dynamics to be quantified in terms of how regions share and combine information. Integrated Information Decomposition ({Phi}ID) separates redundant (the same content present in multiple regions) from synergistic information (new content that emerges only when regions are considered together). Such information-dynamic measures may provide biomarkers relevant to AD risk and progression. MethodsHere we applied integrated information decomposition ({Phi}ID) to resting-state fMRI from the Alzheimers Disease Neuroimaging Initiative (ADNI), to test whether {Phi}ID measures are diagnostically sensitive and track cognition along the AD spectrum. For each region, we computed total synergy and redundancy and compared values across cognitively normal (CN), mild cognitive impairment (MCI), and AD groups. ResultsCompared to CN, AD patients showed a striking synergy reduction across the entire brain, in concert with widespread redundancy increases, particularly in the executive and default mode networks. Transitions from CN to AD included an intermediate MCI decrease in redundancy, possibly reflecting early disease compensation strategies. This AD informational shift from complex higher level information processing to more robust inefficient forms likely reflects a cognitive shift to simpler, less integrative cognitive processes. Indeed, when re-analysing the data according to a standard cognitive clinical test (the Montreal Cognitive Assessment), we found a synergy-redundancy shift in high versus low performers broadly very similar to the CN to AD shift. ConclusionAD shows a clear information-processing signature: reduced global synergy and increased redundancy, especially in the executive control network. These striking results provide powerful insights into the widespread information processing reconfiguration that occurs in AD, with clear changes already emerging at the earlier MCI stage. Further, these results provide a novel route to support early diagnosis and stratification.

neuroscience↗

Neural Markers Of Reduced Arousal And Consciousness In Mild Cognitive Impairment

ObjectivesPeople with Alzheimers Disease (AD) experience changes in their level and content of consciousness, but there is little research on biomarkers of consciousness in pre-clinical AD and MCI. This study investigated whether levels of consciousness are decreased in people with MCI. MethodsA multi-site MEG dataset, BIOFIND, comprising 83 people with MCI and 83 age matched controls, was analysed. Arousal (and drowsiness) was assessed by computing the theta-alpha ratio (TAR). The Lempel-Ziv algorithm (LZ) was used to quantify the information content of brain activity, with higher LZ values indicating greater complexity and potentially a higher level of consciousness. ResultsLZ was lower in the MCI group vs controls, indicating a reduced level of consciousness in MCI. TAR was higher in the MCI group vs controls, indicating a reduced level of arousal (i.e. increased drowsiness) in MCI. LZ was also found to be correlated with MMSE scores, suggesting a direct link between cognitive impairment and level of consciousness in people with MCI. ConclusionsA decline in consciousness and arousal can be seen in MCI. As cognitive impairment worsens, measured by MMSE scores, levels of consciousness and arousal decrease. These findings highlight how monitoring consciousness using biomarkers could help understand and manage impairments found at the preclinical stages of AD. Further research is needed to explore markers of consciousness between people who progress from MCI to dementia and those who do not, and in people with moderate and severe AD, to promote person-centred care.

neuroscience↗